29 Followers on Owler
InhibRx is a California-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights
InhibRx is a California-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
Inhibrx Founder & CEO: Mark Lappe

Founder & CEO

Mark Lappe

CEO Approval Rating

98/100

2010

PublicAcquired by Sanofi S.ANASDAQINBX

Pharmaceuticals & Biotechnology
Pharmaceuticals & Biotech Technology
2836 NAICS listing

Annual Revenue
$1.3M
Employees
172
Funding
$807.8M

News

Leadership Change
Apr 02, 2025
PR Newswire
David Matly is now President at Inhibrx

Inhibrx Competitors

1Alligator Bioscience
2Adimab
3Nektar Therapeutics
4GSK
5Crescendo Biologics
6ALX Oncology
7Polaris
8BioAtla
9Ambrx
10Five Prime
Unlock 17 + competitors

Trending Companies